Thus, the interplay between intrauterine pO2, SPHK expression and So-1-P formation is vital for maintaining placental health and could provide insight into potential therapeutic targets for managing conditions associated with abnormal placentation such as preeclampsia. The gene discussed is SPHK1; the disease is preeclampsia.